Physician profile
Kathryn P Stringer
NPI 1912056755
$927.20
in general payments reported to CMS, 2019-2025
17 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $137 · 2023: $306 · 2024: $83.89 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $201.24 | 2021-2025 | |
| Astellas Pharma US INC | $181.17 | 2023-2025 | Veozah |
| Organon LLC | $69.57 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $68.51 | 2025 | Myfembree |
| Coopersurgical, INC. | $66.73 | 2021-2023 | Paragard T 380a |
| Myovant Sciences INC. | $52.78 | 2021-2022 | |
| Daiichi Sankyo INC. | $50.77 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $41.64 | 2024-2025 | Gardasil 9, Gardasil |
| Glaxosmithkline, LLC. | $36.84 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.37 | 2025 | |
| Biogen, INC. | $25.37 | 2025 | Zurzuvae |
| Baxter Healthcare | $23.98 | 2023 | Tisseel |
| Aspira Women'S Health INC | $22.37 | 2023 | Ova1 |
| Evofem Biosciences, INC. | $16.83 | 2021 | |
| Hologic Sales and Service, LLC | $16.47 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.31 | 2025 | |
| Agile Therapeutics, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.